149 related articles for article (PubMed ID: 11474776)
21. Interactions of cimetidine and ranitidine with aluminum-containing antacids and a clay-containing gastric-protective drug in an "artificial stomach-duodenum" model.
Vatier J; Harman A; Castela N; Droy-Lefaix MT; Farinotti R
J Pharm Sci; 1994 Jul; 83(7):962-6. PubMed ID: 7965675
[TBL] [Abstract][Full Text] [Related]
22. Establishing an in vitro permeation model to predict the in vivo sex-related influence of PEG 400 on oral drug absorption.
Mai Y; Murdan S; Awadi M; Basit AW
Int J Pharm; 2018 May; 542(1-2):280-287. PubMed ID: 29530563
[TBL] [Abstract][Full Text] [Related]
23. Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man.
Lennernäs H; Ahrenstedt O; Hällgren R; Knutson L; Ryde M; Paalzow LK
Pharm Res; 1992 Oct; 9(10):1243-51. PubMed ID: 1448420
[TBL] [Abstract][Full Text] [Related]
24. Regional Intestinal Permeability of Three Model Drugs in Human.
Dahlgren D; Roos C; Lundqvist A; Abrahamsson B; Tannergren C; Hellström PM; Sjögren E; Lennernäs H
Mol Pharm; 2016 Sep; 13(9):3013-21. PubMed ID: 27504798
[TBL] [Abstract][Full Text] [Related]
25. The effects of cigarette smoking on plasma concentrations of gastric antisecretory drugs.
Boyd EJ; Johnston DA; Wormsley KG; Jenner WN; Salanson X
Aliment Pharmacol Ther; 1987 Feb; 1(1):57-65. PubMed ID: 2979213
[TBL] [Abstract][Full Text] [Related]
26. Effect of bupropion on cimetidine and ranitidine absorption in rats.
Tanira MO; Kaka JS; al-Khamis KI
Biopharm Drug Dispos; 1989; 10(1):35-41. PubMed ID: 2493822
[TBL] [Abstract][Full Text] [Related]
27. The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans.
Sandström R; Knutson TW; Knutson L; Jansson B; Lennernäs H
Br J Clin Pharmacol; 1999 Aug; 48(2):180-9. PubMed ID: 10417494
[TBL] [Abstract][Full Text] [Related]
28. [Relation of the kinetics of the antisecretory effect and kinetics of blood concentration in man. Comparing cimetidine and ranitidine].
Raoul JL; Trouvin JH; Farinotti R; Lewin MJ; Bonfils S
Gastroenterol Clin Biol; 1989 Jun; 13(6-7):585-90. PubMed ID: 2753306
[TBL] [Abstract][Full Text] [Related]
29. Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption.
Schulze JD; Waddington WA; Eli PJ; Parsons GE; Coffin MD; Basit AW
Pharm Res; 2003 Dec; 20(12):1984-8. PubMed ID: 14725363
[TBL] [Abstract][Full Text] [Related]
30. Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data.
Sjögren E; Dahlgren D; Roos C; Lennernäs H
Mol Pharm; 2015 Jun; 12(6):2026-39. PubMed ID: 25919764
[TBL] [Abstract][Full Text] [Related]
31. A pharmacokinetic interaction between cimetidine or ranitidine and lornoxicam.
Ravic M; Salas-Herrera I; Johnston A; Turner P; Foley K; Rosenow DE
Postgrad Med J; 1993 Nov; 69(817):865-6. PubMed ID: 8290432
[TBL] [Abstract][Full Text] [Related]
32. Absorption of polar drugs following caecal instillation in healthy volunteers.
Riley SA; Kim M; Sutcliffe F; Rowland M; Turnberg LA
Aliment Pharmacol Ther; 1992 Dec; 6(6):701-6. PubMed ID: 1486155
[TBL] [Abstract][Full Text] [Related]
33. Disposition kinetics of cimetidine and ranitidine in endotoxin pretreated rats.
Kaka JS; Tanira MO; al-Khamis KI
Drug Chem Toxicol; 1989 Mar; 12(1):49-59. PubMed ID: 2714208
[TBL] [Abstract][Full Text] [Related]
34. Predicting human intestinal permeability using single-pass intestinal perfusion in rat.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Azarmi Y; Islambolchilar Z; Barzegar S; Barzegar-Jalali M
J Pharm Pharm Sci; 2007; 10(3):368-79. PubMed ID: 17727800
[TBL] [Abstract][Full Text] [Related]
35. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
36. The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique.
Tannergren C; Knutson T; Knutson L; Lennernäs H
Br J Clin Pharmacol; 2003 Feb; 55(2):182-90. PubMed ID: 12580990
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of cimetidine and ranitidine on the pharmacokinetics of disopyramide in man.
Jou MJ; Huang SC; Kiang FM; Lai MY; Chao PD
J Pharm Pharmacol; 1997 Nov; 49(11):1072-5. PubMed ID: 9401940
[TBL] [Abstract][Full Text] [Related]
38. Intestinal clearance of H2-antagonists.
Hui YF; Kolars J; Hu Z; Fleisher D
Biochem Pharmacol; 1994 Jul; 48(2):229-31. PubMed ID: 7914403
[TBL] [Abstract][Full Text] [Related]
39. Human jejunal effective permeability and its correlation with preclinical drug absorption models.
Lennernäs H
J Pharm Pharmacol; 1997 Jul; 49(7):627-38. PubMed ID: 9255703
[TBL] [Abstract][Full Text] [Related]
40. The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.
Powell JR; Donn KH
J Clin Gastroenterol; 1983; 5 Suppl 1():95-113. PubMed ID: 6140286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
